Atlas Trials

β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation

Clinical trial NCT01944033 · COMPLETED

Trial details

NCT number
NCT01944033
Sponsor
University of Monastir
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Exacerbation of Chronic Obstructive Airways Disease
Start date
2013-07-01
Primary completion
2016-07-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.